Biotech company Morphoceuticals has announced it closed an $8 million Seed-2 funding round led by Prime Movers Lab and initial investor Juvenescence. Seed funding will advance programs using electroceuticals in limb regeneration and amputation stump health.
You may also like
LyGenesis and Imagine Pharma Announce Joint Research Collaboration to Develop Novel Cell Therapies for Patients with Type 1 Diabetes
Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter
Morphoceuticals Raises $8 million to Advance Electroceutical Approach to Regenerative Medicine